Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial.
Ferdinand KC, Pool J, Weitzman R, Purkayastha D, Townsend R. Ferdinand KC, et al. Among authors: purkayastha d. J Clin Hypertens (Greenwich). 2011 May;13(5):366-75. doi: 10.1111/j.1751-7176.2010.00416.x. Epub 2011 Jan 18. J Clin Hypertens (Greenwich). 2011. PMID: 21545398 Clinical Trial.
Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M. Jamerson KA, et al. Among authors: purkayastha d. Am J Hypertens. 2004 Jun;17(6):495-501. doi: 10.1016/j.amjhyper.2004.02.003. Am J Hypertens. 2004. PMID: 15177521 Clinical Trial.
Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study.
Neutel JM, Smith DH, Weber MA, Schofield L, Purkayastha D, Gatlin M. Neutel JM, et al. Among authors: purkayastha d. J Clin Hypertens (Greenwich). 2005 Nov;7(11):641-6; quiz 647-8. doi: 10.1111/j.1524-6175.2005.04615.x. J Clin Hypertens (Greenwich). 2005. PMID: 16278521 Clinical Trial.
72 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page